Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02469691
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GYT | BIS-(2-ACETAMIDO-2-DEOXY-ALPHA- D-GLUCOPYRANOSYLOXYCARBONYL)-4,7,10- TRIOXA-1,13-TRIDECANEDIAMINE | A,B | 2UWZ | 0.71 |  |
EAG | 2-aminoethyl 2-(acetylamino)-2- deoxy-beta-D-glucopyranoside | B,D,E,F,H | 3BZ4 | 0.71 | |
YX1 | 2-deoxy-2-{[(2-hydroxy-1-methylhydrazino)carbonyl]amino}- beta-D-glucopyranose | A,B | 2VUR | 0.72 | |
GTH | 3-O-GLUCOPYRANOSYL-THREONINE-[2- DEOXY-2-ACETAMIDO-GLUCOPYRANOSIDE] | A | 1WCT | 0.72 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8G | 0.72 | |
| AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8F | 0.72 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1LJN | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1ZU0 | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 2HRH | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 1TW5 | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,H | 2HRG | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | 1 | 2BS7 | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7T | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 2QT6 | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1QBB | 0.71 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7S | 0.71 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A,B,C,D | 1N47 | 0.74 | |
| TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A | 2CGZ | 0.74 | |
| TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A,B,C,D | 2D3S | 0.74 | |
| TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A | 2D7R | 0.74 | |
STZ | STREPTOZOTOCIN | A | 2W4X | 0.74 | |
GYU | GLYCOSYLURETHAN | A,B | 2UWG | 0.7 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | A,D,M,N,Z | 2F4V | 0.7 | |
| AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | B | 2F4T | 0.7 | |
FSM | FORSMANN ANTIGEN | A | 2CGY | 0.71 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXV | 0.72 | |
| MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXU | 0.72 | |
AS5 | 2-(acetylamino)-4-O-[2-(acetylamino)- 2-deoxy-alpha-L-gulopyranosyl]- 1,5-anhydro-2-deoxy-D-mannitol | A,B | 2VLC | 0.71 | |